What are the indications for a four-phase liver CT (non-contrast, arterial, portal-venous, and delayed phases)?

Indications for Four-Phase Liver CT

Four-phase liver CT (non-contrast, arterial, portal venous, and delayed phases) is indicated for characterization of indeterminate liver lesions ≥1 cm, particularly in patients with chronic liver disease or known malignancy, where dynamic enhancement patterns are critical for distinguishing hepatocellular carcinoma from other focal liver lesions 1.

Primary Clinical Indications

1. Characterization of Indeterminate Liver Lesions ≥1 cm

The ACR Appropriateness Criteria establish that at least two dynamic phases (arterial and portal venous) are required for characterization of most liver lesions, with the late arterial phase preferred over early arterial phase for maximal lesion enhancement 1. However, four-phase protocols provide superior diagnostic capability:

• Patients with chronic liver disease (cirrhosis, chronic hepatitis B): Multiphase CT is essential per LI-RADS technical recommendations for detecting and characterizing hepatocellular carcinoma (HCC), dysplastic nodules, and other lesions specific to cirrhotic livers 1
• Patients with known extrahepatic malignancy: Four-phase CT helps differentiate metastases from primary liver tumors and benign lesions 1
• Normal liver with indeterminate lesions: Multiphase CT accurately distinguishes benign from malignant lesions in 74-95% of cases 1

2. Detection and Staging of Hepatocellular Carcinoma

The hallmark imaging feature of HCC—arterial hyperenhancement with delayed washout—has 89% sensitivity and 96% specificity, making multiphase imaging essential 2. Research demonstrates that:

• The delayed phase significantly increases HCC detection sensitivity from 88.8% to 92.8% (p<0.05) compared to biphasic (arterial + portal venous) protocols alone 3
• Small HCCs (<3 cm) are optimally detected with arterial phase imaging, as 35 of 109 hepatomas in one study were only visible or most conspicuous during the arterial phase 4
• The delayed phase provides the second-highest liver-tumor contrast after the arterial phase 4

3. Active Surveillance of LI-RADS 3 and 4 Lesions

For patients with chronic liver disease and probable but not definite HCC (LI-RADS 4) or intermediate probability lesions (LI-RADS 3), multiphase CT is appropriate for follow-up imaging to identify progression to definite HCC 2.

Specific Phase Contributions

Non-Contrast Phase

• Limited value for lesion detection alone but useful for:
  • Detecting calcifications
  • Identifying hemorrhage or fat content
  • Serving as baseline for enhancement measurements
  • Evaluating patients with prior liver-directed therapy 2
• Can potentially be omitted in standard protocols without compromising diagnostic accuracy when using modern deep learning analysis, reducing radiation dose 5

Arterial Phase

• Critical for detecting hypervascular lesions, particularly small HCCs
• Provides highest liver-tumor contrast for HCC 4
• Essential for evaluating hepatic and mesenteric vascular anatomy 6

Portal Venous Phase

• Standard phase for general liver parenchymal evaluation
• Limited value for detecting small hepatomas compared to arterial and delayed phases 4
• Important for overall lesion characterization when combined with other phases

Delayed/Equilibrium Phase

• Significantly improves HCC detection (sensitivity increase of 4%, p<0.05) 3
• Demonstrates washout appearance characteristic of HCC
• Provides second-highest liver-tumor contrast after arterial phase 4
• Some tumors are most conspicuous only in this phase 4

Clinical Decision Algorithm

Use four-phase CT when:

1. Characterizing any indeterminate liver lesion ≥1 cm in patients with cirrhosis or chronic hepatitis B
2. Evaluating suspected HCC or following LI-RADS 3/4 lesions
3. Staging known HCC
4. Characterizing lesions in patients with known extrahepatic malignancy
5. When definitive diagnosis (not just benign vs. malignant) is required

Consider three-phase CT (omitting non-contrast) when:

• Standard lesion characterization is needed without prior therapy
• Radiation dose reduction is priority
• No need to assess calcification or hemorrhage

Biphasic CT (arterial + portal venous) may suffice when:

• Initial screening in low-risk patients
• Follow-up of known benign lesions
• General abdominal imaging where liver is not primary focus

Important Caveats

• Timing is critical: Peak aortic enhancement occurs at 24 seconds with 4 mL/sec injection rate; optimal arterial phase acquisition requires precise bolus tracking 4
• Injection rate matters: 4 mL/sec injection provides significantly higher tumor enhancement than 2 mL/sec, improving detection of small hepatomas 4
• Patient factors: The protocol maintains diagnostic accuracy across different BMI ranges 7
• Alternative modalities: MRI with hepatobiliary contrast agents or contrast-enhanced ultrasound may be equivalent or superior alternatives in specific scenarios 1

The evidence strongly supports that the delayed phase is not optional when evaluating for HCC in at-risk patients—it provides statistically significant improvement in detection that directly impacts patient outcomes through earlier diagnosis and treatment 3.